NDC 0591-2132 – Doxylamine succinate and pyridoxine hydrochloride

Doxylamine Succinate 10 mg/1; Pyridoxine Hydrochloride 10 mg/1 · Tablet, Delayed Release · Oral

Human Prescription Drug 1 recall

Product NDC0591-2132

Product details

Brand name
Doxylamine succinate and pyridoxine hydrochloride
Generic name
Doxylamine succinate and pyridoxine hydrochloride
Labeler
Actavis Pharma, Inc.
Dosage form
Tablet, Delayed Release
Route
Oral
Marketing category
ANDA · ANDA205811
Marketed since
June 21, 2019
Listing expires
December 31, 2026
Pharmacologic class
Antihistamine; Vitamin B6 Analog

Active ingredients

Uses, dosage, side effects and warnings for Doxylamine succinate and pyridoxine hydrochloride →

Package NDC codes (1)

Package NDCDescriptionSince
0591-2132-01100 TABLET, DELAYED RELEASE in 1 BOTTLE (0591-2132-01)Jun 21, 2019

Recalls mentioning this NDC

Other Doxylamine succinate and pyridoxine hydrochloride products